New Player In Cancer Biomarker Detection Catching a tumor’s first footprints is the holy grail of cancer research. The ability to detect and treat cancer early would put the collective mind of humanity at ease. Our best bet yet is the liquid biopsy—a minimally...
Antagonists Fight A Good Fight Small molecule inhibitors, also known as antagonists in the industry, fight a good fight. In fact, many drugs on the market today work by inhibiting overactive, disease-associated proteins. Novartis’ (Basel, Switzerland) top...
The Latest In Cancer Diagnostics Hearing the words “it might be cancer” paired with your doctor’s perplexed look is enough to send shockwaves through your body. Getting to the heart of a diagnosis usually requires a surgical biopsy—removal and...
After using diagnostic technology to establish the existence of cancer, determining the severity is the next step toward developing a game plan. If metastasis is in the picture, strengthening your defensive line-up is a must. The dissemination of circulating tumor...
PRIMED TO BEAT PROSTATE CANCER We usually associate vaccines with infectious disease—measles, mumps, and polio. This 20th century miracle of medicine is being rolled out again, but this time with a 21st century mission: target cancer. In this week’s issue, we will...
About Biotech Primer
From startups to the Fortune 500, we train employees at companies of all sizes. We offer customized, in-house courses and open enrollment classes. Visit Biotech Primer for more information.
